
ExxonMobil Holdings Corporation
- Growing?
- Yes: revenue up 33% on a year earlier (quarter ended Sep 2026); earnings per share up 42% over the last four quarters.
- Expensive?
- Pricier than usual: 17.4× trailing earnings; its median since Jan 2022 is 14.1×. Priced 31% above the peer median of 13.4x.
- Analysts?
- 35% of 26 say buy; average 12-month target $185, 9% above today's price.
- Risky?
- About average for a large company: its price swung 27% over the past year (the S&P 500's 14%), and it fell as much as 21% since Nov 2021.
ExxonMobil Holdings Corp is a leading American multinational oil and gas corporation specializing in the exploration, production, refining, and marketing of crude oil, natural gas, and petrochemicals.
More about ExxonMobil Holdings
The company operates through various segments, including Upstream, Downstream, and Chemical, offering products under brands such as Exxon, Mobil, and Esso.
Market Position
As one of the world's largest publicly traded energy providers and chemical manufacturers, ExxonMobil Holdings Corp holds a significant share in the global energy market, leveraging its extensive resources and technological expertise to maintain a competitive edge.
Key Segments
- Upstream: Focuses on the exploration and production of oil and natural gas.
- Downstream: Involves refining, marketing, and distribution of petroleum products.
- Chemical: Engages in the production of petrochemicals and specialty products.
Highlights:
-, Published on Thursday, August 27
How has the stock done?
Over the past month XOM fell 1.4%; the energy ETF (XLE) fell 2.5% and the S&P 500 fell 2.7%.
Over the past six months XOM rose 12.7%; the energy ETF (XLE) rose 11.7% and the S&P 500 rose 2.6%.
Over the past year XOM rose 43.7%; the energy ETF (XLE) rose 42.6% and the S&P 500 rose 10.8%.
Over five years XOM rose 166.0%; the energy ETF (XLE) rose 123.6% and the S&P 500 rose 62.0%.
From Mar 30, 2026 to Jun 29, 2026, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 0.6% the other way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Oct 30, 2026 | ended Sep 2026 | $113.2B (+33% vs a year earlier) | $4.23 vs $4.03 (beat) | −2.0% | −9.5% |
| Jul 31, 2026 | ended Jun 2026 | $116.0B (+42% vs a year earlier) | $3.52 vs $3.63 (missed) | −1.2% | −2.5% |
| May 1, 2026 | ended Mar 2026 | $85.1B (+2% vs a year earlier) | $2.09 vs $1.01 (beat) | −0.4% | −6.3% |
| Jan 30, 2026 | ended Dec 2025 | $82.3B (−1% vs a year earlier) | $1.71 vs $1.69 (beat) | −1.5% | +6.1% |
| Oct 31, 2025 | ended Sep 2025 | $85.3B (−5% vs a year earlier) | — | −0.8% | +2.2% |
| Aug 1, 2025 | ended Jun 2025 | $81.5B (−12% vs a year earlier) | — | −3.8% | −4.3% |
| May 2, 2025 | ended Mar 2025 | $83.1B (0% vs a year earlier) | — | −2.4% | +1.4% |
| Jan 31, 2025 | ended Dec 2024 | $83.4B (−1% vs a year earlier) | — | −2.3% | −0.6% |
| Nov 1, 2024 | ended Sep 2024 | $90.0B (−1% vs a year earlier) | — | +1.6% | +3.7% |
| Aug 2, 2024 | ended Jun 2024 | $93.1B (+12% vs a year earlier) | — | −1.9% | +1.6% |
| Apr 26, 2024 | ended Mar 2024 | $83.1B (−4% vs a year earlier) | — | −1.4% | −4.4% |
| Feb 2, 2024 | ended Dec 2023 | $84.3B (−12% vs a year earlier) | — | −0.8% | −0.6% |
| Oct 27, 2023 | ended Sep 2023 | $90.8B (−19% vs a year earlier) | — | −1.6% | +0.2% |
| Jul 28, 2023 | ended Jun 2023 | $82.9B (−28% vs a year earlier) | — | +1.7% | +1.9% |
| Apr 28, 2023 | ended Mar 2023 | $86.6B (−4% vs a year earlier) | — | −1.8% | −7.0% |
| Jan 31, 2023 | ended Dec 2022 | $95.4B (+12% vs a year earlier) | — | +1.0% | +1.2% |
| Oct 28, 2022 | ended Sep 2022 | $112.1B (+52% vs a year earlier) | — | +3.0% | +4.4% |
| Jul 29, 2022 | ended Jun 2022 | $115.7B (+71% vs a year earlier) | — | +2.0% | −4.5% |
| Apr 29, 2022 | ended Mar 2022 | $90.5B (+53% vs a year earlier) | — | −0.9% | +5.1% |
| Feb 1, 2022 | ended Dec 2021 | $85.0B (+83% vs a year earlier) | — | +6.1% | +5.7% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $113.2B in the quarter ended Sep 2026, up 33% from a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $95.4B | +12% |
| Mar 2023 | $86.6B | −4% |
| Jun 2023 | $82.9B | −28% |
| Sep 2023 | $90.8B | −19% |
| Dec 2023 | $84.3B | −12% |
| Mar 2024 | $83.1B | −4% |
| Jun 2024 | $93.1B | +12% |
| Sep 2024 | $90.0B | −1% |
| Dec 2024 | $83.4B | −1% |
| Mar 2025 | $83.1B | 0% |
| Jun 2025 | $81.5B | −12% |
| Sep 2025 | $85.3B | −5% |
| Dec 2025 | $82.3B | −1% |
| Mar 2026 | $85.1B | +2% |
| Jun 2026 | $116.0B | +42% |
| Sep 2026 | $113.2B | +33% |
Revenue went from $413.7B in FY22 to $332.2B in FY25; net income from $55.7B to $28.8B.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY22 | $413.7B | $55.7B |
| FY23 | $344.6B | $36.0B |
| FY24 | $349.6B | $33.7B |
| FY25 | $332.2B | $28.8B |
A year earlier $1.76
Diluted, from SEC filings
The P/E of 17.4× over the 42% EPS growth of the last four quarters; near 1 or below is cheap for the growth
Quarters: ExxonMobil Holdings Corporation's SEC filings, named by the month they end. Revenue here is ExxonMobil Holdings Corporation's total revenues and other income, with its share of its equity affiliates' income and its other income; it tags its sales and other operating revenue only with a concept of its own, which SEC's data does not carry. Fiscal years: ExxonMobil Holdings Corporation's annual reports to the SEC.
How it makes money
Of every $100 in revenue, $8.7 ends up as net income. Net margin fell from 13.5% to 8.7% over the past 3 years.
−3.5 pts over 3 years
−5.3 pts over 3 years
−4.8 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: ExxonMobil Holdings Corporation's annual reports to the SEC.
Customers and suppliers
Suppliers
Partners
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| Syncrude | partner · joint venture with it | “Syncrude is a joint venture established to recover shallow deposits of oil sands using open-pit mining methods to extract the crude bitumen, and then upgrade it to produce a high-quality, light (32 degrees API), sweet, synthetic crude oil. Imperial Oil Limited is the owner of a 25 percent interest in the joint venture.” |
| TCO | partner · ExxonMobil Holdings invested in it | “The Corporation holds a 25 percent interest in Tengizchevroil, LLP (TCO), which operates the Tengiz and Korolev oil fields in Kazakhstan, and a 16.8 percent working interest in the Kashagan field in Kazakhstan.” |
| CPC | partner · ExxonMobil Holdings invested in it | “Oil production from those operations is exported primarily through the Caspian Pipeline Consortium (CPC), in which the Corporation holds a 7.5 percent interest.” |
| Barzan Gas Company | partner · joint venture with it | “Barzan Gas Company Limited 7” |
| BEB Erdgas und Erdoel GmbH & Co. KG | partner · joint venture with it | “BEB Erdgas und Erdoel GmbH & Co. KG 50” |
| Coral FLNG | partner · joint venture with it | “Coral FLNG S.A. 25” |
| Cross Timbers Energy | partner · joint venture with it | “Cross Timbers Energy LLC 50” |
| Golden Pass LNG Terminal | partner · joint venture with it | “Golden Pass LNG Terminal LLC 30” |
| Golden Pass Pipeline | partner · joint venture with it | “Golden Pass Pipeline LLC 30” |
| Marine Well Containment Company | partner · joint venture with it | “Marine Well Containment Company LLC 13” |
| Permian Highway Pipeline | partner · joint venture with it | “Permian Highway Pipeline LLC 17” |
| South Hook LNG Terminal Company | partner · joint venture with it | “South Hook LNG Terminal Company Limited 24” |
| Alberta Products Pipe Line | partner · joint venture with it | “Alberta Products Pipe Line Ltd. 45” |
| Fujian Refining & Petrochemical | partner · joint venture with it | “Fujian Refining & Petrochemical Co. Ltd. 25” |
| Gulf Coast Growth Ventures | partner · joint venture with it | “Gulf Coast Growth Ventures LLC 50” |
| Infineum USA | partner · joint venture with it | “Infineum USA L.P. 50” |
| Permian Express Partners | partner · joint venture with it | “Permian Express Partners LLC 12” |
| Saudi Aramco Mobil Refinery Company | partner · joint venture with it | “Saudi Aramco Mobil Refinery Company Ltd. 50” |
| FuelCell Energy (10-K filed Dec 18, 2025) | calls it a customer | “On January 31, 2024, the Company received a purchase order valued at $11.6 million from Esso Nederland B.V. (“Esso”), an affiliate of Exxon Mobil Corporation and EMTEC, for fuel cell modules as well as engineering, procurement, fabrication, testing and delivery services required for the construction and implementation of the modular point source carbon capture pilot plant at the Rotterdam Project. During the year ended October 31, 2025, the Company and Esso executed three change orders totaling $5.0 million to the original purchase order, which increased the total purchase order value to $16.6 million.” |
| FuelCell Energy (10-K filed Dec 18, 2025) | licensing deal with it | “In June 2019, we entered into a license agreement with EMTEC to facilitate the further development of our carbon capture platform (the “EMTEC License Agreement”). Pursuant to the EMTEC License Agreement, we granted EMTEC and its affiliates a non-exclusive, worldwide, fully-paid, perpetual, irrevocable, non-transferable license and right to use our patents filed on or before April 30, 2021, and any data, know-how, improvements, equipment designs, methods, processes and the like provided directly by the Company or its affiliates to EMTEC or its affiliates under any agreement, or otherwise, on or before April 30, 2021, to the extent it is useful to research, develop and commercially exploit carbonate fuel cells in applications in which the fuel cells concentrate carbon dioxide from external industrial and power sources and for any other purpose attendant thereto or associated therewith, in exchange for a $10 million payment.” |
Only the companies ExxonMobil Holdings names in its 10-K filed Feb 18, 2026 (SEC). Named in other companies' filings: those whose own latest annual report or an 8-K since names ExxonMobil Holdings. The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words.
Is it expensive?
P/E of 17.4x, above the peer median of 13.4x, so it needs earnings to keep growing to hold up.
Priced 31% above the peer median of 13.4x.
Show the data
| Company | P/E (trailing) |
|---|---|
| XOM · ExxonMobil Holdings Corporation | 17.4× |
| CVX · Chevron Corporation | 15.8× |
| NFG · National Fuel Gas Company | 10.9× |
At 17.4× trailing earnings XOM is above most of its range since Jan 2022; the median is 14.1×.
Show the data
| Date | Trailing P/E |
|---|---|
| Feb 4, 2022 | 15.1× |
| May 6, 2022 | 15.2× |
| Aug 8, 2022 | 9.7× |
| Nov 4, 2022 | 9.2× |
| Feb 7, 2023 | 8.7× |
| May 9, 2023 | 7.4× |
| Aug 9, 2023 | 8.8× |
| Nov 7, 2023 | 10.3× |
| Feb 8, 2024 | 11.7× |
| May 9, 2024 | 14.5× |
| Aug 9, 2024 | 14.2× |
| Nov 7, 2024 | 15.1× |
| Feb 11, 2025 | 14.2× |
| May 13, 2025 | 14.5× |
| Aug 13, 2025 | 15.3× |
| Nov 11, 2025 | 17.4× |
| Feb 12, 2026 | 22.4× |
| May 14, 2026 | 25.7× |
| Aug 14, 2026 | 20.6× |
| Nov 12, 2026 | 17.4× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $185, 9% above the current price; 35% of 26 analysts rate it a buy; earnings beat estimates in 3 of the last 4 quarters.
Buy or Strong Buy: 9 analysts (35%). Sell or Strong Sell: 0.
Over the past year the average of the analysts' latest price targets went from $131.33 to $184.73 (+41%), while XOM went from $118.79 to $169.78 (+43%). In the past three months targets were raised 12 times and cut once. 3 upgrades and 4 downgrades over the year; the latest: Wells Fargo moved it to Equal-Weight from Overweight on Oct 1, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Nov 7, 2026 | Freedom Broker | Target raised | Hold | $162.00, was $142.00 |
| Nov 4, 2026 | Citigroup | Target raised | Neutral | $175.00, was $155.00 |
| Nov 4, 2026 | TD Cowen | Target raised | Buy | $193.00, was $180.00 |
| Nov 2, 2026 | UBS | Target raised | Buy | $213.00, was $199.00 |
| Nov 2, 2026 | Morgan Stanley | Target raised | Overweight | $187.00, was $185.00 |
| Nov 2, 2026 | Evercore ISI Group | Target raised | Outperform | $200.00, was $185.00 |
| Nov 2, 2026 | Wells Fargo | Target raised | Equal-Weight | $189.00, was $182.00 |
| Oct 19, 2026 | Barclays | Target raised | Overweight | $200.00, was $177.00 |
| Oct 15, 2026 | Morgan Stanley | Target raised | Overweight | $185.00, was $177.00 |
| Oct 1, 2026 | Wells Fargo | Downgrade | Equal-Weight, was Overweight | $182.00 |
| Sep 28, 2026 | TD Cowen | Target raised | Buy | $180.00, was $168.00 |
| Sep 3, 2026 | Piper Sandler | Target raised | Neutral | $185.00, was $158.00 |
| Aug 19, 2026 | Morgan Stanley | Target raised | Overweight | $177.00, was $168.00 |
| Aug 17, 2026 | Barclays | Target cut | Overweight | $177.00, was $182.00 |
| Aug 7, 2026 | TD Cowen | Target raised | Buy | $168.00, was $155.00 |
| Aug 4, 2026 | Freedom Broker | Upgrade | Hold, was Sell | $142.00, was $130.00 |
| Jul 28, 2026 | B of A Securities | Downgrade | Neutral, was Buy | $158.00, was $154.00 |
| Jul 9, 2026 | Mizuho | Target cut | Neutral | $170.00, was $175.00 |
| Jul 2, 2026 | TD Cowen | Target cut | Buy | $155.00, was $172.00 |
| Jun 29, 2026 | Morgan Stanley | Target cut | Overweight | $168.00, was $171.00 |
| Jun 16, 2026 | B of A Securities | Upgrade | Buy, was Neutral | $154.00 |
| May 27, 2026 | Mizuho | Target raised | Neutral | $175.00, was $159.00 |
| May 26, 2026 | Barclays | Target raised | Overweight | $182.00, was $163.00 |
| May 11, 2026 | Bernstein | Target cut | Outperform | $182.00, was $195.00 |
| May 5, 2026 | RBC Capital | Target kept | Sector Perform | $180.00 |
| May 4, 2026 | UBS | Target raised | Buy | $174.00, was $171.00 |
| Apr 22, 2026 | Scotiabank | Target raised | Sector Outperform | $163.00, was $128.00 |
| Apr 21, 2026 | Wolfe Research | Downgrade | Peer Perform, was Outperform | — |
| Apr 17, 2026 | BNP Paribas | Upgrade | Neutral, was Underperform | $165.00, was $125.00 |
| Apr 17, 2026 | Morgan Stanley | Target cut | Overweight | $171.00, was $172.00 |
| Apr 10, 2026 | TD Cowen | Target cut | Buy | $172.00, was $175.00 |
| Apr 9, 2026 | JP Morgan | Target raised | Overweight | $170.00, was $140.00 |
| Apr 9, 2026 | Piper Sandler | Target cut | Overweight | $182.00, was $186.00 |
| Apr 9, 2026 | RBC Capital | Target raised | Sector Perform | $180.00, was $160.00 |
| Apr 9, 2026 | Jefferies | Target raised | Buy | $184.00, was $178.00 |
| Apr 9, 2026 | Wells Fargo | Target raised | Overweight | $185.00, was $183.00 |
| Apr 8, 2026 | Wolfe Research | Target cut | Outperform | $153.00, was $158.00 |
| Apr 2, 2026 | Citigroup | Target raised | Neutral | $175.00, was $150.00 |
| Mar 27, 2026 | Morgan Stanley | Target raised | Overweight | $172.00, was $134.00 |
| Mar 20, 2026 | HSBC | Target raised | Hold | $158.00, was $135.00 |
| Mar 17, 2026 | Mizuho | Target raised | Neutral | $162.00, was $140.00 |
| Mar 16, 2026 | Barclays | Target raised | Overweight | $163.00, was $145.00 |
| Mar 12, 2026 | Piper Sandler | Target raised | Overweight | $186.00, was $145.00 |
| Mar 2, 2026 | Citigroup | Target raised | Neutral | $150.00, was $118.00 |
| Mar 2, 2026 | B of A Securities | Target raised | Neutral | $151.00, was $135.00 |
| Feb 24, 2026 | Wells Fargo | Target raised | Overweight | $183.00, was $156.00 |
| Feb 3, 2026 | TD Cowen | Target raised | Buy | $145.00, was $135.00 |
| Feb 3, 2026 | Barclays | Target raised | Overweight | $145.00, was $140.00 |
| Feb 2, 2026 | RBC Capital | Target raised | Sector Perform | $150.00, was $145.00 |
| Feb 2, 2026 | Wells Fargo | Target cut | Overweight | $156.00, was $158.00 |
| Jan 28, 2026 | B of A Securities | Target raised | Neutral | $135.00, was $129.00 |
| Jan 23, 2026 | Morgan Stanley | Target cut | Overweight | $134.00, was $137.00 |
| Jan 21, 2026 | Barclays | Target raised | Overweight | $140.00, was $130.00 |
| Jan 8, 2026 | Piper Sandler | Target cut | Overweight | $142.00, was $144.00 |
| Jan 6, 2026 | Freedom Broker | Downgrade | Sell, was Hold | $123.00 |
| Jan 5, 2026 | Bernstein | Target cut | Outperform | $137.00, was $142.00 |
| Dec 12, 2025 | TD Cowen | Target raised | Buy | $135.00, was $128.00 |
| Dec 12, 2025 | Mizuho | Target raised | Neutral | $132.00, was $129.00 |
| Dec 11, 2025 | Wells Fargo | Target raised | Overweight | $158.00, was $156.00 |
| Dec 11, 2025 | B of A Securities | Target cut | Neutral | $118.00, was $119.00 |
| Dec 10, 2025 | Citigroup | Target raised | Neutral | $118.00, was $115.00 |
| Dec 10, 2025 | Jefferies | Target raised | Buy | $148.00, was $146.00 |
| Dec 10, 2025 | Morgan Stanley | Target raised | Overweight | $137.00, was $135.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $1.69 | $1.71 | +1.2% |
| Mar ’26 | $1.01 | $2.09 | +106.9% |
| Jun ’26 | $3.63 | $3.52 | −3.0% |
| Sep ’26 | $4.03 | $4.23 | +5.0% |
The day after each of these reports the stock moved −1.5% (Dec 2025, beat); −0.4% (Mar 2026, beat); −1.2% (Jun 2026, missed); −2.0% (Sep 2026, beat).
For the quarter ending Dec 2026 (ExxonMobil Holdings reports on Jan 29, 2027), analysts expect adjusted earnings of $4.08 a share, 138% more than the $1.71 of a year earlier, and revenue of $118.6B, up 44% on a year earlier. For the fiscal year ending Dec 2027, they expect adjusted earnings of $12.44 a share, and revenue of $435.0B, up 1% on the year before's estimate.
Adjusted. Dec 2025: $1.71; range $3.50 to $4.71; 15 analysts
Dec 2025: $82.3B; range $81.2B to $142.8B; 10 analysts
Adjusted. The year to Dec 2026: $13.64 expected, with a quarter far from its estimate; range $8.77 to $16.50; 23 analysts
The year to Dec 2026: $432.5B expected; range $322.0B to $541.8B; 14 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026, results Jan 29, 2027 | EPS (adjusted) | $4.08 | $3.50 to $4.71 | 15 | $1.71 (Dec 2025) | +138% |
| Quarter ending Dec 2026, results Jan 29, 2027 | Revenue | $118.6B | $81.2B to $142.8B | 10 | $82.3B (Dec 2025) | +44% |
| Quarter ending Mar 2027 | EPS (adjusted) | $3.43 | $1.68 to $4.34 | 16 | $2.09 (Mar 2026) | — |
| Quarter ending Mar 2027 | Revenue | $97.4B | $72.6B to $111.8B | 6 | $85.1B (Mar 2026) | +14% |
| Year ending Dec 2026 | EPS (adjusted) | $13.64 | $12.74 to $14.54 | 17 | — | — |
| Year ending Dec 2026 | Revenue | $432.5B | $395.5B to $457.1B | 14 | $332.2B (year to Dec 2025) | +30% |
| Year ending Dec 2027 | EPS (adjusted) | $12.44 | $8.77 to $16.50 | 23 | $13.64 (expected, year to Dec 2026) | — |
| Year ending Dec 2027 | Revenue | $435.0B | $322.0B to $541.8B | 14 | $432.5B (expected, year to Dec 2026) | +1% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $43.0B in free cash flow over the year, of which $37.8B went back to shareholders (dividends plus buybacks), leaving $5.2B in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $70.6B |
| Capex | −$27.6B |
| Free cash flow | $43.0B |
| Dividends | −$17.3B |
| Buybacks | −$20.5B |
| Cash retained | $5.2B |
For every $100 of market cap, the company generates about $6.2 in free cash flow a year.
For every $100 of market cap, you receive about $2.4 in dividends a year.
Dividends plus buybacks over the last four quarters: for every $100 of market cap, about $5.5 went back to shareholders.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Dec 2023 | $7.5B | $3.8B | $4.7B |
| Mar 2024 | $9.6B | $3.8B | $3.0B |
| Jun 2024 | $4.3B | $4.3B | $5.3B |
| Sep 2024 | $11.4B | $4.2B | $5.5B |
| Dec 2024 | $5.4B | $4.4B | $5.8B |
| Mar 2025 | $7.1B | $4.3B | $4.8B |
| Jun 2025 | $5.3B | $4.3B | $5.0B |
| Sep 2025 | $6.1B | $4.2B | $5.1B |
| Dec 2025 | $5.2B | $4.4B | $5.4B |
| Mar 2026 | $2.2B | $4.3B | $4.9B |
| Jun 2026 | $17.0B | $4.3B | $5.1B |
| Sep 2026 | $18.5B | $4.3B | $5.1B |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter.
Financial health
Current ratio 1.2, short-term debt is manageable; debt-to-equity 0.1, debt is very low and the balance sheet is solid.
Assets that can be turned into cash soon are 1.2x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.1 of debt (leases not counted). The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $10.7B against debt of $37.2B. Lease obligations of $6.3B are not counted: they are rent owed, not money borrowed. It also holds $32.9B of long-term investments, $271M of them securities it could sell.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
In the filings of 3 members of Congress and 3 funds whose copy leaves XOM out (on the exchange, not in the app yet): Fisher Asset Management, Swiss National Bank, Rob Bresnahan, Mirae Asset Global Investments, Rob Wittman, Dan Meuser.
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 7 held XOM at the end of their latest quarter, Q3 2026. Over that quarter 1 cut and 6 bought new. The largest of them is Fisher Asset Management, 31.93M shares worth $5.2B at Sep 30, 2026.
6 of them new holders
Over their latest quarter
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Fisher Asset Management | Q3 2026 | 31.93M | $5.2B | +31.93M | New | Nov 6, 2026 |
| Swiss National Bank | Q3 2026 | 11.34M | $1.8B | +11.34M | New | Nov 12, 2026 |
| National Pension Service | Q3 2026 | 9.70M | $1.6B | +9.70M | New | Nov 12, 2026 |
| First Eagle Investment Management | Q3 2026 | 5.09M | $828M | +5.09M | New | Nov 10, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 1.24M | $202M | +1.24M | New | Nov 3, 2026 |
| Gardner Russo & Quinn | Q3 2026 | 150,689 | $24.5M | −30,511 | −17% | Nov 12, 2026 |
| Markel Group | Q3 2026 | 60,400 | $9.8M | +60,400 | New | Oct 30, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of XOM at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end.
Are insiders buying or selling?
Officers and directors sold $2.4M of XOM on the open market in the 12 months to Nov 13, 2026; none bought. The largest was Darrin L Talley (VP - Corp Strategic Planning), who sold $2.4M in 7 sales.
7 sales
0 purchases
Share of the sales' value
Show every trade
| Date | Insider | Role | Trade | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Darrin L Talley | VP - Corp Strategic Planning | Sale | 1,080 | $155.50 | $168K | Mar 17, 2026 |
| Mar 2, 2026 | Darrin L Talley | VP - Corp Strategic Planning | Sale | 2,150 | $157.82 | $339K | Mar 3, 2026 |
| Feb 9, 2026 | Darrin L Talley | VP - Corp Strategic Planning | Sale | 3,230 | $149.18 | $482K | Feb 9, 2026 |
| Feb 2, 2026 | Darrin L Talley | VP - Corp Strategic Planning | Sale | 650 | $139.75 | $91K | Feb 3, 2026 |
| Feb 2, 2026 | Darrin L Talley | VP - Corp Strategic Planning | Sale | 4,350 | $139.75 | $608K | Feb 3, 2026 |
| Dec 17, 2025 | Darrin L Talley | VP - Corp Strategic Planning | Sale | 3,000 | $117.19 | $352K | Dec 18, 2025 |
| Dec 15, 2025 | Darrin L Talley | VP - Corp Strategic Planning | Sale | 3,000 | $118.75 | $356K | Dec 15, 2025 |
From the Form 4s filed with the SEC about ExxonMobil Holdings Corporation (40 in the 12 months): purchases (code P) and sales (code S) on the open market by its officers and directors, at the price each filing gives (often an average of the day's trades). A sale is a 10b5-1 sale when its filing says it was made under such a plan, set up in advance. Not counted: 42 other transactions (grants, shares withheld for tax and gifts).